In a dizzying span of seven months in 2022, Bristol Myers Squibb gained FDA approval for three new products, touting each with the potential to achieve $4 billion in peak sales. While multiple myeloma ...

If you have psoriatic arthritis (PsA), you may be familiar with sore fingers, stiff wrists, and the frustration of struggling with formerly simple tasks like buttoning a shirt or chopping vegetables.

Researchers have figured out how psoriasis can quietly turn into joint disease for some patients. Immune cells formed in inflamed skin can travel through the blood and reach the joints, where they ...

Maintaining a healthy weight plays an important role in managing an inflammatory condition like psoriatic arthritis. Overweight and obesity have been linked to an increased risk of psoriatic arthritis ...

Philip Mease, MD, discusses the different treatment options now available for patients with psoriasis and psoriatic arthritis. Psoriatic arthritis (PsA) affects roughly 30% of patients with psoriasis, ...

Toenail's owner Alexa Freemyer amassed a large following for posting videos of her host of exotic and farm animals Tabitha Parent is a writer at PEOPLE covering entertainment and culture. She joined ...

Please provide your email address to receive an email when new articles are posted on . Patients treated with concomitant ixekizumab and tirzepatide met PsA and weight reduction endpoints. Safety data ...

Elaine Chen, a national biotech reporter, is the co-author of The Readout, a newsletter about the business, science, and politics of biotech. Elaine Chen covers biotech, co-writes The Readout ...

In case you've faced some hurdles solving the clue, Toenail treatment, for short, we've got the answer for you. Crossword puzzles offer a fantastic opportunity to engage your mind, enjoy leisure time, ...

Four years of long-term data confirm the continued safety of the drug tildrakizumab in patients with psoriatic arthritis. The data presented at the American College of Rheumatology Convergence ...

Patients with psoriatic arthritis (PsA) treated with biologics had lower rates of cardiovascular events and all-cause and cardiovascular mortality but a higher risk for infection-related admissions ...